Eva Baecklund

7.9k total citations · 1 hit paper
75 papers, 4.9k citations indexed

About

Eva Baecklund is a scholar working on Rheumatology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Eva Baecklund has authored 75 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Rheumatology, 34 papers in Pathology and Forensic Medicine and 32 papers in Genetics. Recurrent topics in Eva Baecklund's work include Chronic Lymphocytic Leukemia Research (32 papers), Lymphoma Diagnosis and Treatment (32 papers) and Rheumatoid Arthritis Research and Therapies (29 papers). Eva Baecklund is often cited by papers focused on Chronic Lymphocytic Leukemia Research (32 papers), Lymphoma Diagnosis and Treatment (32 papers) and Rheumatoid Arthritis Research and Therapies (29 papers). Eva Baecklund collaborates with scholars based in Sweden, United States and Denmark. Eva Baecklund's co-authors include Johan Askling, Lars Klareskog, Nils Feltelius, Karin E. Smedby, Christer Sundström, Carin Backlin, Richard Rosenquist, Anders Ekbom, Anca I. Catrina and Anders Ekbom and has published in prestigious journals such as International Journal of Cancer, Annals of the Rheumatic Diseases and Transplantation.

In The Last Decade

Eva Baecklund

72 papers receiving 4.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis

2006 667 citations Eva Baecklund, Anastasia Iliadou et al. Arthritis & Rheumatism profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Eva Baecklund	2.4k	1.5k	1.1k	1.0k	934	75	4.9k
O. Fain	1.4k 0.6×	634 0.4×	978 0.9×	430 0.4×	888 1.0×	203	4.2k
Xavier Mariette	2.4k 1.0×	1.4k 0.9×	852 0.7×	1.2k 1.2×	1.4k 1.5×	70	7.5k
A. Mékinian	1.4k 0.6×	697 0.5×	552 0.5×	365 0.4×	1.1k 1.2×	231	4.4k
Maria Greenwald	2.7k 1.2×	694 0.5×	868 0.8×	1.2k 1.2×	1.5k 1.6×	76	5.1k
Hideto Kameda	2.6k 1.1×	628 0.4×	631 0.6×	398 0.4×	1.2k 1.2×	196	4.3k
Luca Quartuccio	1.6k 0.7×	465 0.3×	379 0.3×	345 0.3×	760 0.8×	204	4.1k
Philippe Casassus	1.1k 0.4×	604 0.4×	773 0.7×	2.0k 1.9×	674 0.7×	80	6.1k
Alexandre Karras	880 0.4×	492 0.3×	673 0.6×	227 0.2×	1.3k 1.4×	164	5.1k
Fabrizio Cantini	4.8k 2.0×	402 0.3×	1.3k 1.1×	207 0.2×	1.8k 1.9×	173	7.6k
Brigitte Bader‐Meunier	1.8k 0.7×	322 0.2×	447 0.4×	306 0.3×	1.9k 2.0×	212	5.8k

Countries citing papers authored by Eva Baecklund

Since Specialization

Citations

This map shows the geographic impact of Eva Baecklund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Baecklund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Baecklund more than expected).

Fields of papers citing papers by Eva Baecklund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Baecklund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Baecklund. The network helps show where Eva Baecklund may publish in the future.

Co-authorship network of co-authors of Eva Baecklund

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Baecklund. A scholar is included among the top collaborators of Eva Baecklund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Baecklund. Eva Baecklund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saevarsdóttir, Saedís, Lina-Marcela Díaz-Gallo, Lars Alfredsson, et al.. (2023). Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis. Lara D. Veeken. 63(5). 1221–1229. 1 indexed citations

Karpouzas, George, Zoltán Szekanecz, Eva Baecklund, et al.. (2023). Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance. Therapeutic Advances in Musculoskeletal Disease. 15. 1759720X231201047–1759720X231201047. 16 indexed citations

Cordtz, René, Johan Askling, Bénédicte Delcoigne, et al.. (2022). Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study. RMD Open. 8(2). e002776–e002776. 2 indexed citations

Frisell, Thomas, Hannah Bower, Eva Baecklund, et al.. (2022). POS0637 SAFETY OF b/tsDMARDs FOR RA AS USED IN CLINICAL PRACTICE - RESULTS FROM THE LAST DECADE OF THE ARTIS PROGRAM. Annals of the Rheumatic Diseases. 81. 587–588. 2 indexed citations

Kinch, Amelie, Eva Baecklund, Daniël G. M. Molin, et al.. (2021). Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders. Acta Oncologica. 60(6). 771–778. 2 indexed citations

Veldwijk, Jorien, Mats Hansson, Eva Baecklund, et al.. (2021). Does being exposed to an educational tool influence patient preferences? The influence of an educational tool on patient preferences assessed by a discrete choice experiment.. Patient Education and Counseling. 104(10). 2577–2585. 9 indexed citations

Bower, Hannah, Thomas Frisell, Daniela Di Giuseppe, et al.. (2021). POS1169 IMPACT OF THE COVID-19 PANDEMIC ON MORBIDITY AND MORTALITY AMONG SWEDISH PATIENTS WITH INFLAMMATORY JOINT DISEASES VERSUS THE GENERAL POPULATION. Annals of the Rheumatic Diseases. 80. 864–865. 1 indexed citations

Hellgren, Karin, Daniela Di Giuseppe, Karin E. Smedby, et al.. (2020). Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs—a Swedish cohort study of risks by time, drug and lymphoma subtype. Lara D. Veeken. 60(2). 809–819. 27 indexed citations

Arkema, Elizabeth V., et al.. (2020). SAT0069 TUBERCULOSIS IN BIOLOGIC-NAÏVE PATIENTS WITH RHEUMATOID ARTHRITIS - RISK FACTORS AND TUBERCULOSIS CHARACTERISTICS. Annals of the Rheumatic Diseases. 79. 969–969.

10.

Valachis, Antonios, et al.. (2019). Autoimmune disease in patients with diffuse large B-cell lymphoma: occurrence and impact on outcome. Acta Oncologica. 58(8). 1170–1177. 13 indexed citations

11.

Eriksson, Niclas, et al.. (2019). Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long‐term follow‐up of predictors, surveillance, and outcome in clinical practice. International Journal of Rheumatic Diseases. 22(7). 1226–1232. 25 indexed citations

12.

Kinch, Amelie, Christer Sundström, Eva Baecklund, et al.. (2018). Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation. Leukemia & lymphoma. 60(2). 376–384. 30 indexed citations

13.

Arkema, Elizabeth V., Jerker Jonsson, Eva Baecklund, et al.. (2014). Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?. Annals of the Rheumatic Diseases. 74(6). 1212–1217. 75 indexed citations

14.

Askling, Johan, Ronald van Vollenhoven, Fredrik Granath, et al.. (2009). Cancer risk in patients with rheumatoid arthritis treated with anti–tumor necrosis factor α therapies: Does the risk change with the time since start of treatment?. Arthritis & Rheumatism. 60(11). 3180–3189. 189 indexed citations

15.

Sokka, Tuulikki, Hannu Kautiainen, S. Toloza, et al.. (2007). QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Annals of the Rheumatic Diseases. 66(11). 1491–1496. 159 indexed citations

16.

Askling, Johan, Michael Fored, Lena Brandt, et al.. (2006). TNF-antagonist treatment and risk of hospitalisation for cardiovascular disease. Results from the National Swedish Monitoring-Program for Biologies in Ra (ARTIS).. Arthritis & Rheumatism. 54.

17.

Askling, Johan, Michael Fored, Lena Brandt, et al.. (2006). TNF-antagonist treatment and risk of hospitalisation for infection. Results from the National Swedish Monitoring-Program for Biologics in RA (ARTIS).. Arthritis & Rheumatism. 54. 1 indexed citations

18.

Baecklund, Eva, Carin Backlin, Anastasia Iliadou, et al.. (2006). Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis. Arthritis & Rheumatism. 54(12). 3774–3781. 51 indexed citations

19.

Askling, Johan, C. Michael Fored, Lena Brandt, et al.. (2005). Risk of tuberculosis in rheumatoid arthritis and following anti-TNF treatment. Preliminary results of an ongoing Swedish monitoring-programme of biologics in RA. Annals of the Rheumatic Diseases. 64. 3 indexed citations

20.

Askling, Johan, C. Michael Fored, Lena Brandt, et al.. (2005). Risk of cardiovascular morbidity and mortality following TNF-blockade. Preliminary results of an ongoing Swedish monitoring-programme of biologics in RA. Annals of the Rheumatic Diseases. 64. 448–449. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact